Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Depreciation and Depletion: 2017-2025

Historic Depreciation and Depletion for Collegium Pharmaceutical (COLL) over the last 6 years, with Sep 2025 value amounting to $1.0 million.

  • Collegium Pharmaceutical's Depreciation and Depletion rose 9.20% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year increase of 14.24%. This contributed to the annual value of $3.9 million for FY2024, which is 10.30% up from last year.
  • Collegium Pharmaceutical's Depreciation and Depletion amounted to $1.0 million in Q3 2025, which was down 8.99% from $1.1 million recorded in Q2 2025.
  • Over the past 5 years, Collegium Pharmaceutical's Depreciation and Depletion peaked at $1.1 million during Q2 2025, and registered a low of $424,000 during Q4 2021.
  • For the 3-year period, Collegium Pharmaceutical's Depreciation and Depletion averaged around $964,636, with its median value being $949,000 (2023).
  • Data for Collegium Pharmaceutical's Depreciation and Depletion shows a peak YoY spiked of 129.74% (in 2021) over the last 5 years.
  • Collegium Pharmaceutical's Depreciation and Depletion (Quarterly) stood at $424,000 in 2021, then spiked by 94.58% to $825,000 in 2022, then climbed by 15.03% to $949,000 in 2023, then climbed by 9.69% to $1.0 million in 2024, then rose by 9.20% to $1.0 million in 2025.
  • Its Depreciation and Depletion stands at $1.0 million for Q3 2025, versus $1.1 million for Q2 2025 and $1.1 million for Q1 2025.